My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 653

    1.

    Key scientific issues in the health risk assessment of trichloroethylene.

    Chiu WA, Caldwell JC, Keshava N, Scott CS.

    Environ Health Perspect. 2006 Sep;114(9):1445-9. Review.PMID: 16966103 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Issues in the pharmacokinetics of trichloroethylene and its metabolites.

    Chiu WA, Okino MS, Lipscomb JC, Evans MV.

    Environ Health Perspect. 2006 Sep;114(9):1450-6. Review.PMID: 16966104 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Trichloroethylene cancer epidemiology: a consideration of select issues.

    Scott CS, Chiu WA.

    Environ Health Perspect. 2006 Sep;114(9):1471-8. Review.PMID: 16966107 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Key issues in the role of peroxisome proliferator-activated receptor agonism and cell signaling in trichloroethylene toxicity.

    Keshava N, Caldwell JC.

    Environ Health Perspect. 2006 Sep;114(9):1464-70. Review.PMID: 16966106 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene.

    Clewell HJ, Andersen ME.

    Crit Rev Toxicol. 2004 Sep-Oct;34(5):385-445. Review.PMID: 15560567 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comments on article "Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene" by Clewell and Andersen.

    Caldwell JC, Evans MV, Marcus AH, Scott CS, Chiu WA, Okino MS, Preuss PW.

    Crit Rev Toxicol. 2006 Mar;36(3):291-4; discussion 295-8.PMID: 16686425 [PubMed - indexed for MEDLINE]Related articles

    7.

    Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis.

    Caldwell JC, Keshava N.

    Environ Health Perspect. 2006 Sep;114(9):1457-63. Review.PMID: 16966105 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Difficulty of mode of action determination for trichloroethylene: An example of complex interactions of metabolites and other chemical exposures.

    Caldwell JC, Keshava N, Evans MV.

    Environ Mol Mutagen. 2008 Mar;49(2):142-54. Review.PMID: 17973308 [PubMed - indexed for MEDLINE]Related articles

    9.

    Framework for metals risk assessment.

    Fairbrother A, Wenstel R, Sappington K, Wood W.

    Ecotoxicol Environ Saf. 2007 Oct;68(2):145-227.PMID: 17889701 [PubMed - indexed for MEDLINE]Related articles

    10.

    Trichloroethylene health risk assessment: a new and improved process.

    Maull EA, Cogliano VJ, Scott CS, Barton HA, Fisher JW, Greenberg M, Rhomberg L, Sorgen SP.

    Drug Chem Toxicol. 1997 Nov;20(4):427-42.PMID: 9433671 [PubMed - indexed for MEDLINE]Related articles

    11.

    Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene.

    Moore MM, Harrington-Brock K.

    Environ Health Perspect. 2000 May;108 Suppl 2:215-23. Review.PMID: 10807553 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop.

    Bogdanffy MS, Daston G, Faustman EM, Kimmel CA, Kimmel GL, Seed J, Vu V.

    Toxicol Sci. 2001 May;61(1):18-31. Review.PMID: 11294970 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models.

    Fisher JW, Allen BC.

    Risk Anal. 1993 Feb;13(1):87-95.PMID: 8451463 [PubMed - indexed for MEDLINE]Related articles

    14.

    Genetic signature for human risk assessment: lessons from trichloroethylene.

    Shiao YH.

    Environ Mol Mutagen. 2009 Jan;50(1):68-77. Review.PMID: 19031419 [PubMed - indexed for MEDLINE]Related articles

    15.

    Personal exposure meets risk assessment: a comparison of measured and modeled exposures and risks in an urban community.

    Payne-Sturges DC, Burke TA, Breysse P, Diener-West M, Buckley TJ.

    Environ Health Perspect. 2004 Apr;112(5):589-98.PMID: 15064166 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The perils and promise of modern risk assessment: the example of trichloroethylene.

    Kester JE, Clewell HJ 3rd.

    Clin Occup Environ Med. 2004 Aug;4(3):497-512, vi-vii.PMID: 15325318 [PubMed - indexed for MEDLINE]Related articles

    17.

    The U.S. Environmental Protection Agency's risk assessment guidelines.

    Jarabek AM, Farland WH.

    Toxicol Ind Health. 1990 Oct;6(5):199-216. Review.PMID: 2274984 [PubMed - indexed for MEDLINE]Related articles

    18.

    A trichloroethylene risk assessment using a Monte Carlo analysis of parameter uncertainty in conjunction with physiologically-based pharmacokinetic modeling.

    Cronin WJ 4th, Oswald EJ, Shelley ML, Fisher JW, Flemming CD.

    Risk Anal. 1995 Oct;15(5):555-65.PMID: 7501875 [PubMed - indexed for MEDLINE]Related articles

    19.

    Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans.

    Allen BC, Fisher JW.

    Risk Anal. 1993 Feb;13(1):71-86.PMID: 8451462 [PubMed - indexed for MEDLINE]Related articles

    20.

    Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites.

    Fisher JW.

    Environ Health Perspect. 2000 May;108 Suppl 2:265-73. Review.PMID: 10807557 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity